$82.45
Price
$11.2B
Market Cap
19.3
P/E Ratio
16.0
Forward P/E
$4.28
EPS (TTM)
—
Dividend Yield
$630M
Cash
$119M
Total Debt
113M
Shares Out
$51.79
$101.40
52-Week Range
Institutional Ownership of GLOBUS MEDICAL INC - A
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Sequoia Fund|Ruane Cunniff
|
6.0K | $517649 | $89.92 | -14.14% |
Trading Activity for GLOBUS MEDICAL INC - A
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| BUY | NEW | 6.0K | $517649 | $89.92 | |
Insider Trading for GLOBUS MEDICAL INC - A
6 Months Insider Sentiment
Buy $0
Sell $2.6M
0
Buys
4
Sells
-2.6M
Net
0
Grants
Largest
$1.7M
Kline
$877K
C
$363K
Kline
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 08, 2026 | Kyle Kline | Senior Vice President, CFO | EXERCISE | 3.6K | $51.87 | $186K |
| Jan 08, 2026 | Leslie V Norwalk | Director | SELL | 2.0K | $101.10 | $202K |
| Jan 08, 2026 | Kyle Kline | Senior Vice President, CFO | SELL | 3.6K | $101.10 | $363K |
| Dec 12, 2025 | Leslie V Norwalk | Director | SELL | 4.0K | $88.85 | $355K |
| Dec 08, 2025 | Paul David C | Executive Chairman | EXERCISE | 34.4K | $25.52 | $877K |
| Dec 01, 2025 | Kyle Kline | Senior Vice President, CFO | SELL | 18.5K | $90.00 | $1.7M |
| Dec 01, 2025 | Kyle Kline | Senior Vice President, CFO | EXERCISE | 5.0K | $56.43 | $282K |
| Dec 01, 2025 | Kyle Kline | Senior Vice President, CFO | EXERCISE | 4.9K | $63.68 | $312K |
| Dec 01, 2025 | Kyle Kline | Senior Vice President, CFO | EXERCISE | 3.6K | $53.14 | $194K |